BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19815240)

  • 1. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
    Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
    J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
    Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
    Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients.
    Poredos P; Jug B
    Angiology; 2007; 58(3):309-15. PubMed ID: 17626985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry.
    Parhofer KG; Zeymer U; Stark RG; Binz C; Schwertfeger M; Bhatt DL; Steg PG; Röther J;
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):51-6. PubMed ID: 19834877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA).
    Monreal M; Alvarez L; Vilaseca B; Coll R; Suárez C; Toril J; Sanclemente C;
    Eur J Intern Med; 2008 May; 19(3):192-7. PubMed ID: 18395163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in cardiovascular mortality in smokers, past-smokers and non-smokers: findings from the FRENA registry.
    Suriñach JM; Alvarez LR; Coll R; Carmona JA; Sanclemente C; Aguilar E; Monreal M;
    Eur J Intern Med; 2009 Sep; 20(5):522-6. PubMed ID: 19712858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
    Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Steg PG; Cannon CP; Brennan DM; Bhatt DL;
    Crit Pathw Cardiol; 2009 Jun; 8(2):91-7. PubMed ID: 19417637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
    Bhatt DL; Peterson ED; Harrington RA; Ou FS; Cannon CP; Gibson CM; Kleiman NS; Brindis RG; Peacock WF; Brener SJ; Menon V; Smith SC; Pollack CV; Gibler WB; Ohman EM; Roe MT;
    Eur Heart J; 2009 May; 30(10):1195-202. PubMed ID: 19339264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
    J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State.
    Berger JS; Petersen JL; Brown DL
    Circ Cardiovasc Interv; 2009 Aug; 2(4):317-22. PubMed ID: 20031734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease.
    McDermott MM; Mandapat AL; Moates A; Albay M; Chiou E; Celic L; Greenland P
    Arch Intern Med; 2003 Oct; 163(18):2157-62. PubMed ID: 14557213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease.
    Diehm C; Allenberg JR; Pittrow D; Mahn M; Tepohl G; Haberl RL; Darius H; Burghaus I; Trampisch HJ;
    Circulation; 2009 Nov; 120(21):2053-61. PubMed ID: 19901192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry.
    Barba R; Bisbe J; Pedrajas JN; Toril J; Monte R; Muñoz-Torrero JF; Monreal M;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):457-63. PubMed ID: 19369873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
    Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease.
    Mechtouff L; Touzé E; Steg PG; Ohman EM; Goto S; Hirsch AT; Röther J; Aichner FT; Weimar C; Bhatt DL; Alberts MJ; Mas JL;
    J Intern Med; 2010 Jun; 267(6):621-33. PubMed ID: 20210837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
    Boden WE; Cherr GS; Eagle KA; Cannon CP; Califf RM; Hirsch AT; Alberts MJ; Criqui M; Creager MA; Massaro JM; D'Agostino RB; Steg PG; Bhatt DL;
    Crit Pathw Cardiol; 2010 Sep; 9(3):116-25. PubMed ID: 20802264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between site of initial symptoms and subsequent progression of disease in a prospective study of atherosclerosis progression in patients receiving long-term treatment for symptomatic peripheral arterial disease.
    Nicoloff AD; Taylor LM; Sexton GJ; Schuff RA; Edwards JM; Yeager RA; Landry GJ; Moneta GL; Porter JM;
    J Vasc Surg; 2002 Jan; 35(1):38-46; discussion 46-7. PubMed ID: 11802131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year costs in patients with a history of or at risk for atherothrombosis in the United States.
    Mahoney EM; Wang K; Cohen DJ; Hirsch AT; Alberts MJ; Eagle K; Mosse F; Jackson JD; Steg PG; Bhatt DL;
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):38-45. PubMed ID: 20031786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.